JULIA GILBERT: Open Payments
NPI 1306171624 · PORTSMOUTH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$604 in 31 payments from 15 companies in 2025. Trend: 2023 $1,609 · 2024 $1,651 · 2025 $604
Food & beverage: $604
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $137 |
| Amgen Inc. | 3 | $56 |
| Novo Nordisk Inc | 3 | $52 |
| ABBVIE INC. | 3 | $51 |
| GlaxoSmithKline, LLC. | 3 | $44 |
| Lilly USA, LLC | 3 | $42 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| PFIZER INC. | 2 | $30 |
Products named: BREZTRI, OTEZLA, TRELEGY ELLIPTA, MOUNJARO, Auvelity, VRAYLAR, XIFAXAN, REXULTI.
Industry payments across OH — which companies pay providers there.
